AFIB · As filed with the SEC

Acutus Medical cash flow statement, by quarter

The statement as Acutus Medical presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Statements of Cash Flows · USD thousands

USD thousands	Q4 2024^† 3 months ended Dec 31, 2024	Q3 2024^† 3 months ended Sep 30, 2024	Q2 2024^† 3 months ended Jun 30, 2024	Q1 2024 3 months ended Mar 31, 2024
Cash flows from operating activities
Net loss	(1,406)^†	(5,607)^†	(914)^†	(1,620)
Less: Loss on discontinued operations	95^†	4,799^†	552^†	(435)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	62^†	73^†	76^†	86
Non-cash stock-based compensation expense	0^†	128^†	129^†	202
Accretion of discounts on marketable securities, net	0^†	0^†	(5)^†	(23)
Amortization of debt issuance costs	471^†	168^†	205^†	87
Amortization of operating lease right-of-use assets	188^†	184^†	180^†	178
Gain on sale of business, net	(2,718)^†	(2,435)^†	(2,869)^†	(2,792)
Change in fair value of warrant liability	(108)^†	174^†	(564)^†	283
Change in fair value of contingent consideration	0^†	0^†	0^†	0
Changes in operating assets and liabilities:
Accounts receivable	(549)^†	(1,177)^†	(1,503)^†	(819)
Inventory	2,401^†	1,022^†	675^†	(1,610)
Employer retention credit receivable	0^†	0^†	0^†	0
Prepaid expenses and other current assets	(238)^†	104^†	65^†	117
Other assets	—	—	—	0
Accounts payable	(435)^†	28^†	(1,482)^†	404
Accrued liabilities	1,196^†	11^†	(562)^†	(891)
Operating lease liabilities	—	—	—	(117)
Operating lease liabilities	(234)^†	(228)^†	—	—
Other long-term liabilities	0^†	0^†	0^†	0
Net cash used in operating activities - continuing operations	(1,275)^†	(2,756)^†	(6,204)^†	(6,950)
Net cash used in operating activities - discontinued operations	(2,783)^†	(942)^†	(771)^†	(9,979)
Net cash used in operating activities	(4,058)^†	(3,698)^†	(6,975)^†	(16,929)
Cash flows from investing activities
Proceeds from sale of business	5,437^†	2,959^†	2,976^†	7,300
Purchases of available-for-sale marketable securities	0^†	0^†	0^†	0
Sales of available-for-sale marketable securities	0^†	0^†	—	—
Maturities of available-for-sale marketable securities	0^†	0^†	1,000^†	1,750
Purchases of property and equipment	36^†	(5)^†	(38)^†	(105)
Net cash provided by investing activities - continuing operations	5,473^†	2,954^†	4,438^†	8,945
Net cash provided by (used in) investing activities - discontinued operations	0^†	23^†	31^†	285
Net cash provided by investing activities	5,473^†	2,977^†	4,469^†	9,230
Cash flows from financing activities
Repayment of debt	0^†	0^†	—	—
Proceeds from the exercise of stock options	0^†	0^†	0^†	0
Repurchase of common shares to pay employee withholding taxes	—	0^†	—	—
Proceeds from employee stock purchase plan	0^†	0^†	—	—
Payment of contingent consideration	0^†	—	—	—
Net cash used in financing activities - continuing operations	(225)^†	0^†	(2,625)^†	0
Net cash used in financing activities - discontinued operations	0^†	0^†	1^†	(42)
Net cash used in financing activities	(225)^†	0^†	(2,624)^†	(42)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	234^†	(11)^†	(2)^†	0
Net change in cash, cash equivalents and restricted cash	1,424^†	(732)^†	(5,132)^†	(7,741)
Cash, cash equivalents and restricted cash, at the beginning of the period	12,595	13,327	18,459	26,200
Cash, cash equivalents and restricted cash, at the end of the period	14,019	12,595	13,327	18,459
Supplemental disclosure of cash flow information:
Cash paid for interest	1,150^†	833^†	1,294^†	1,267
Supplemental disclosure of noncash investing and financing activities:
Accounts receivable from sale of business	(2,640)^†	10,314^†	(10,740)^†	4,904
Change in unrealized (gain) loss on marketable securities	0^†	0^†	70^†	(70)
Change in unpaid purchases of property and equipment	—	0^†	0^†	0

† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.